<DOC>
	<DOCNO>NCT00001679</DOCNO>
	<brief_summary>This study evaluate 2-5 year outcome cohort 250 patient early synovitis , recruit protocol 94-AR-0194 ( The Pathogenesis Inflammatory Synovitis : A Study Early Arthritis ) . Clinical , radiographic , functional outcome parameter , particularly relate articular damage functional loss , evaluate relate back clinical , serologic , immunogenetic , pathologic variable identify onset arthropathy . A model generate incorporates weigh variable order determine diagnostic prognostic marker early stage arthritis . Synovial tissue sample obtain entire cohort initial visit protocol 94-AR-0194 . Studies biopsies far demonstrated evidence presence infectious agent proportion sample , generate information regard cytokine profile early stage synovitis . In attempt define pathogenetic mechanism synovitis longitudinally , biopsy repeat select subset cohort . Specific question answer relate persistence microbial agent synovium , evolution cellular molecular mechanism mediate invasive , destructive potential synovial lesion . It anticipate study prove valuable clinician attempt stratify patient therapeutic strategy , early disease course . They also prove valuable enhance understanding pathogenetic mechanism synovitis .</brief_summary>
	<brief_title>Prognostic Indicators Determinants 2-5 Year Outcome Cohort Early Synovitis Patients</brief_title>
	<detailed_description>This study evaluate 2-5 year outcome cohort 250 patient early synovitis , recruit protocol 94-AR-0194 ( The Pathogenesis Inflammatory Synovitis : A Study Early Arthritis ) . Clinical , radiographic , functional outcome parameter , particularly relate articular damage functional loss , evaluate relate back clinical , serologic , immunogenetic , pathologic variable identify onset arthropathy . A model generate incorporates weigh variable order determine diagnostic prognostic marker early stage arthritis . Synovial tissue sample obtain entire cohort initial visit protocol 94-AR-0194 . Studies biopsies far demonstrated evidence presence infectious agent proportion sample , generate information regard cytokine profile early stage synovitis . In attempt define pathogenetic mechanism synovitis longitudinally , biopsy repeat select subset cohort . Specific question answer relate persistence microbial agent synovium , evolution cellular molecular mechanism mediate invasive , destructive potential synovial lesion . It anticipate study prove valuable clinician attempt stratify patient therapeutic strategy , early disease course . They also prove valuable enhance understanding pathogenetic mechanism synovitis .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Synovitis</mesh_term>
	<mesh_term>Arthritis , Reactive</mesh_term>
	<criteria>All patient recruit , complete , 1 year follow protocol 94AR0194 . FOR ENTRY ONTO 98AR0150 JOINT MRI : Patients currently evaluate NIH Protocol 94AR0194 98AR1050 . Must least one clinically active arthritic joint consideration percutaneous needle synovial biopsy . No patient follow : cardiac pacemaker , auto defribrillators , neural stimulators , aneurysm clip , metallic prosthesis , cochlear ( ear ) implant , implant device ( pump , infusion device , etc . ) , metal fragment eye , shrapnel injury . No patient exceed size limitation MRI scanner . No patient suffer claustrophobia . No patient previous anaphylactoid reaction gadoliniumbased contrast material . No patient currently pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1999</verification_date>
	<keyword>Immunogenetics</keyword>
	<keyword>Joint Damage</keyword>
	<keyword>Reactive Arthritis</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Synovium</keyword>
	<keyword>Synovitis</keyword>
</DOC>